Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United Sts Brent Oil Fd Lp Unit
BNO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
Enanta Pharmaceuticals (ENTA)
- 13.160
- -0.580-4.22%
Close Jul 20 15:59 ET
- 13.160
- 0.0000.00%
Post 19:34 ET
382.67MMarket Cap-5.06P/E (TTM)
13.990High12.985Low169.21KVolume13.990Open13.740Prev Close2.23MTurnover0.84%Turnover RatioLossP/E (Static)29.08MShares17.15052wk High3.28P/B263.98MFloat Cap6.45052wk Low--Dividend TTM20.06MShs Float127.770Historical High--Div Yield TTM7.31%Range %4.090Historical Low13.184Avg Price1Lot Size
Enanta Pharmaceuticals (ENTA) News
Enanta Enters $75 Million At-the-Market Stock Offering Agreement
Express News | Enanta Pharmaceuticals - Enters Open Market Sale Agreement With Jefferies - SEC Filing
Enanta Faces Patent Setback in Paxlovid Litigation
Express News | Enanta Pharmaceuticals - Federal Circuit Affirms '953 Patent Claims Invalid on June 23, 2026 - SEC Filing
Pfizer Patent Win Against Enanta Over COVID Pill Upheld by Appeals Court
AbbVie, Enanta Announce EU Label Expansion for Hepatitis C Therapy, Maviret
Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Relmada Therapeutics (RLMD)
Enanta Pharmaceuticals Advances RSV Drug to Phase 2/3 Trial After US FDA Meeting
Express News | Enanta Pharmaceuticals - Registrational Phase 2B/3 Trial in High-Risk Adults With Rsv to Start Q4 2026; With Topline Phase 2B Data Expected in 2027
Express News | Enanta Pharmaceuticals - Phase 2B Trial in Pediatric Rsv Patients to Start Q3 2026
Express News | Enanta Pharmaceuticals Announces Advancement of Its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (Rsv)
Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Why Phreesia Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
European Medicines Agency Announces Meeting Highlights From The Committee For Medicinal Products for Human Use, May 18-21
Enanta Pharmaceuticals | 10-Q: Quarterly report
Enanta Pharma Shares Are Trading Lower. The Company Reported Q2 Financial Results.
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Orchestra BioMed Holdings (OBIO)
Enanta Pharmaceuticals | 8-K: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
Enanta Pharma Q2 EPS $(0.45) Beats $(0.49) Estimate, Sales $17.159M Beat $17.092M Estimate
Express News | Enanta Pharmaceuticals Q2 EPS USD -0.45
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Latest: Citing a senior Iranian official, foreign media reported on the 20th that intermediaries in Iran-U.S. negotiations have presented Te
Futubull Options Sir
Jul 20 17:36
Hormuz Standoff and Soaring Oil Prices: Will the June CPI Relief Be Wiped Out?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.